Ex vivo drug sensitivity screening in multiple myeloma identifies drug combinations that act synergistically

The management of multiple myeloma (MM) is challenging: An assortment of available drug combinations adds complexity to treatment selection, and treatment resistance frequently develops. Given the heterogeneous nature of MM, personalized testing tools are required to identify drug sensitivities. To...

Descripción completa

Detalles Bibliográficos
Autores principales: Giliberto, Mariaserena, Thimiri Govinda Raj, Deepak B., Cremaschi, Andrea, Skånland, Sigrid S., Gade, Alexandra, Tjønnfjord, Geir E., Schjesvold, Fredrik, Munthe, Ludvig A., Taskén, Kjetil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936517/
https://www.ncbi.nlm.nih.gov/pubmed/35148457
http://dx.doi.org/10.1002/1878-0261.13191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936517/
https://www.ncbi.nlm.nih.gov/pubmed/35148457
http://dx.doi.org/10.1002/1878-0261.13191

Ejemplares similares